Skip to main content

Advertisement

Table 1 Statistical tests on the patient subtypes enriched in each group from K = 3 clustering results. No statistic test was performed for HER2 (and TN) status, due to the fact that more than 25 % patients do not contain HER2 status

From: Integrative analysis of somatic mutations and transcriptomic data to functionally stratify breast cancer patients

  Total ER+ ER- χ2 adj-P value PR+ PR- χ2 adj-P value HER2+ HER2- Triple -
Group1 41 14 26 0.00075 13 26 0.00658 8 23 16
Group2 304 233 68 0.700 205 95 0.488 55 158 28
Group3 100 85 12 0.0619 68 30 0.6476 15 53 5
Total (with sig mutation and matching RNAseq) 445 332 106   286 151   78 235 49
Total in TCGA 876 634 187   548 267   136 447 90